Showing results (21-30 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|November 18, 2011
Radioprotective effect of Ocimum sanctum and amifostine on the salivary gland of rats after therapeutic radioiodine exposureLebana J Joseph, Uma S Bhartiya, Yogita S Raut, et al.Cancer Biotherapy & Radiopharmaceuticals|June 5, 2012
High-mobility group boxes mediate cell proliferation and radiosensitivity via retinoblastoma-interaction-dependent and -independent mechanismsLi-Li Wang, Qing-Hui Meng, Yang Jiao, et al.Cancer Biotherapy & Radiopharmaceuticals|May 17, 2016
Decreased LRIG1 in Human Ovarian Cancer Cell SKOV3 Upregulates MRP-1 and Contributes to the Chemoresistance of VP16Hua Yang, Jun Yao, Jiangpin Yin, et al.Cancer Biotherapy & Radiopharmaceuticals|April 5, 2016
Lentivirus-Mediated Knockdown of CTHRC1 Inhibits Osteosarcoma Cell Proliferation and MigrationWeilin Sang, Libo Zhu, Jinzhong Ma, et al.Cancer Biotherapy & Radiopharmaceuticals|September 15, 2017
Bulk Scale Formulation of Therapeutic Doses of Clinical Grade Ready-to-Use 177Lu-DOTA-TATE: The Intricate Radiochemistry AspectsAnupam Mathur, Vrinda Prashant, Navin Sakhare, et al.Cancer Biotherapy & Radiopharmaceuticals|June 17, 2016
Radiolabeling of Extracellular Vesicles with (99m)Tc for Quantitative In Vivo Imaging StudiesZoltán Varga, István Gyurkó, Krisztina Pálóczi, et al.Cancer Biotherapy & Radiopharmaceuticals|March 18, 2016
The Result of Multiple I-131 Treatments on the Effective Half-Life of Retained Radioactivity in Patients Ablated for Differentiated Thyroid Cancer: Possible Evidence for Thyroid Remnant Function ImpairmentDemetrios OkkalidesCancer Biotherapy & Radiopharmaceuticals|December 2, 2015
Development of (177)Lu-DOTA-Dendrimer and Determination of Its Effect on Metal and Ion Levels in Tumor TissueLuciana Kovacs, Marcos Tassano, Mirel Cabrera, et al.Cancer Biotherapy & Radiopharmaceuticals|October 21, 2017
PERK-Phosphorylated eIF2α Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast CancerWeiwei Zou, Yu Bai, Xilong Wang, et al.Cancer Biotherapy & Radiopharmaceuticals|October 21, 2017
HIF-1α Promotes Breast Cancer Cell MCF-7 Proliferation and Invasion Through Regulating miR-210Yang Zhang, Jinyin Yan, Lu Wang, et al.Pageof 223